Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Pdr1p
|
CAGL0M01760g
|
PubMed
Tsai HF et al., Antimicrob Agents Chemother, 2006 Apr;50(4):1384-92Tsai HF et al., Antimicrob Agents Chemother, 2006 Apr;50(4):1384-92 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Cycloheximide |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Itraconazole |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Oligomycin |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Voriconazole |
PubMed
Vermitsky JP et al., Mol Microbiol, 2006 Aug;61(3):704-22Vermitsky JP et al., Mol Microbiol, 2006 Aug;61(3):704-22 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
CBS138 |
Control |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
PubMed
Ferrari S et al., PLoS Pathog, 2009 Jan;5(1):e1000268Ferrari S et al., PLoS Pathog, 2009 Jan;5(1):e1000268 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CBS138 |
Control |
Indirect |
Western blot - wt vs TF mutant |
Positive |
CBS138 |
Control |
PubMed
Tsai HF et al., Antimicrob Agents Chemother, 2010 Aug;54(8):3308-17Tsai HF et al., Antimicrob Agents Chemother, 2010 Aug;54(8):3308-17 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
PubMed
Paul S et al., Eukaryot Cell, 2011 Feb;10(2):187-97Paul S et al., Eukaryot Cell, 2011 Feb;10(2):187-97 |
Direct |
EMSA |
N/A |
CBS138 |
Fluconazole |
Indirect |
Luciferase - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
PubMed
Caudle KE et al., Eukaryot Cell, 2011 Mar;10(3):373-83Caudle KE et al., Eukaryot Cell, 2011 Mar;10(3):373-83 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
CBS138 |
Control |
PubMed
Ferrari S et al., PLoS One, 2011 Mar 9;6(3):e17589Ferrari S et al., PLoS One, 2011 Mar 9;6(3):e17589 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CBS138 |
Fluconazole |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CBS138 |
Control |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
CBS138 |
Control |
PubMed
Noble JA et al., Antimicrob Agents Chemother, 2013 Feb;57(2):959-67Noble JA et al., Antimicrob Agents Chemother, 2013 Feb;57(2):959-67 |
Indirect |
Microarray analysis - wt vs TF overexpression |
Positive |
CBS138 |
Control |
PubMed
Steier Z et al., Antimicrob Agents Chemother, 2013 Nov;57(11):5543-7Steier Z et al., Antimicrob Agents Chemother, 2013 Nov;57(11):5543-7 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CBS138 |
5-Flucytosine |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CBS138 |
Control |
PubMed
Paul S et al., Antimicrob Agents Chemother, 2014 Nov;58(11):6904-12Paul S et al., Antimicrob Agents Chemother, 2014 Nov;58(11):6904-12 |
Direct |
ChIP |
N/A |
CBS138 |
Control |
PubMed
Pais P et al., Mol Cell Proteomics, 2016 Jan;15(1):57-72Pais P et al., Mol Cell Proteomics, 2016 Jan;15(1):57-72 |
Indirect |
Proteomics - wt vs TF mutant |
Positive |
CBS138 |
Clotrimazole |
PubMed
Pais P et al., Front Microbiol., 2016;7():2045Pais P et al., Front Microbiol., 2016;7():2045 |
Indirect |
iTRAQ-MS - wt vs TF mutant |
Positive |
CBS138 |
BM medium growth + 4microg/mL5-flucytosine |
PubMed
Khakhina S et al., Mol Microbiol, 2018 Mar;107(6):747-764Khakhina S et al., Mol Microbiol, 2018 Mar;107(6):747-764 |
Indirect |
RT-PCR - wt vs TF overexpression |
Positive |
ATCC2001 |
Minimal medium growth at 30.C (control) |
Direct |
lacZ - wt vs mutant promoter sequence |
Positive |
ATCC2001 |
Minimal medium growth at 37.C (control) |
PubMed
Ni Q et al., Mycoses, 2018 Jul;61(7):430-440Ni Q et al., Mycoses, 2018 Jul;61(7):430-440 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
CG1 |
YPD growth, 37.C |
PubMed
Whaley SG et al., mSphere, 2018 Jan-Feb;3(1):Whaley SG et al., mSphere, 2018 Jan-Feb;3(1): |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
SM1 |
YPD 30.C |
PubMed
Tian Y et al., FEMS Yeast Res, 2018 Jun 1;18(4):Tian Y et al., FEMS Yeast Res, 2018 Jun 1;18(4): |
Direct |
ChIP |
N/A |
TYR |
YPD 30.C |
Direct |
RT-PCR - wt vs mutant promoter sequence |
Positive |
TYR |
YPD 30.C |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
TYR/TYS |
YPD 30.C |
PubMed
, , ;():, , ;(): |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
KUE100 |
Antioxidant exposure (YPD + SkQ1) |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
KUE100 |
Antioxidant exposure (YPD + C12TPP) |
PubMed
, , ;():, , ;(): |
Direct |
ChIP |
N/A |
Wild5/6 |
YPD 30.C |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
Wild5/6 |
YPD 30.C |
PubMed
Simonicova L et al., PLoS Genet, 2020 Aug;16(8):e1009005Simonicova L et al., PLoS Genet, 2020 Aug;16(8):e1009005 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
ATCC2001 |
Minimal medium growth at 30.C (control) |
Indirect |
Western blot - wt vs TF mutant |
Positive |
ATCC2001 |
Minimal medium growth at 30.C (control) |